ZLD 0.00% 75.0¢ zelira therapeutics limited

Ann: Investor Presentation - Non-deal Roadshow, page-22

  1. 3,871 Posts.
    lightbulb Created with Sketch. 374
    Good presentation. Further showing that the market is not interested in potential, even when it is short term realization.
    When product is being moved and cash is rolling in regularly the market will take the punt.
    Before that there is the Doctor hurdle that is in the way. As a prescribed drug it will have to be accepted by the medical profession who are notoriously conservative. So we should expect a bit of time for it to become accepted.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.